ATAI Life Sciences (ATAI) Price & Analysis

Compare

1,964 Followers

ATAI Stock Chart & Stats

$3.87

-$0.11(-6.29%)

At close: Jan 08 4:00 PM EST

$3.87

-$0.11(-6.29%)

Day’s Range― - ―

52-Week Range$1.15 - $6.75

Previous CloseN/A

Volume1.44M

Average Volume (3M)3.09M

Market Cap

$1.41B

Enterprise Value$1.04B

Total Cash (Recent Filing)$114.61M

Total Debt (Recent Filing)$2.96M

Price to Earnings (P/E)―

Beta1.26

Next Earnings

Mar 26, 2026

EPS Estimate

-0.11

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.28

Shares Outstanding363,214,600

10 Day Avg. Volume3,178,884

30 Day Avg. Volume3,093,898

Financial Highlights & Ratios

PEG Ratio>-0.01

Price to Book (P/B)1.83

Price to Sales (P/S)691.60

P/FCF Ratio-2.58

Enterprise Value/Market Cap0.74

Enterprise Value/Revenue344.47

Enterprise Value/Gross Profit-132.94

Enterprise Value/Ebitda-7.17

Forecast

1Y Price Target

$13.13

Price Target Upside239.28% Upside

Rating ConsensusStrong Buy

Number of Analyst Covering9

EPS Forecast (FY)-0.44

Revenue Forecast (FY)$500.00K

Bulls Say, Bears Say

Bulls Say

Clinical TrialsPhase IIb trial of BPL-003 in treatment-resistant depression met its primary endpoint, demonstrating a clinical benefit with rapid and sustained effects.

Pipeline DevelopmentA differentiated pipeline of neuropsychiatric agents with lead assets following the SPRAVATO playbook in treatment-resistant depression.

Regulatory ProgressBreakthrough Therapy Designation for BPL-003 in treatment-resistant depression underscores strong momentum and reinforces its leadership in the field.

Bears Say

Safety ConcernsOne serious adverse event of suicidal ideation was reported, highlighting a potential risk factor in the treatment.

ATAI Life Sciences News

AtaiBeckley completes redomiciliation to the U.S.

AtaiBeckley announced the completion of the redomiciliation of the parent company of the AtaiBeckley group from a Netherlands...

6d ago

ATAI

Midday Fly By: Wegovy weight loss pill approved, ServiceNow inks security deal

Fed rate cut bets have been pared by traders after the blowout GDP report that showed higher-than-expected growth...

13d ago

AME

Coty downgraded, Spruce Biosciences initiated: Wall Street’s top analyst calls

The most talked about and market moving research calls around Wall Street are now in one place. Here...

13d ago

AME

Atai Beckley initiated with a Buy at JonesResearch

JonesResearch analyst Justin Walsh initiated coverage of Atai Beckley (ATAI) with a Buy rating and $16 price target...

13d ago

ATAI

Atai Beckley added to Nasdaq Biotechnology Index

Atai Beckley (ATAI) announced its common stock has been added to the NASDAQ Biotechnology Index (NBI), effective prior...

13d ago

ATAI

Jefferies sees potential tailwind forming for psychedelics from marijuana shift

Jefferies analyst Andrew Tsai notes that the highest level of the U.S. government has signed an executive order...

17d ago

ATAI

CYBN

Atai Beckley management to meet with Cantor

Cantor holds a webinar entitled, “Let’s Do More Psychedelical” on December 17 at 11 am hosted by Cantor.Webcast...

21d ago

ATAI

Psychedelic: Atai Beckley granted U.S. patent for EMP-01

In this week’s “Psychedelic,” The Fly’s recurring series focused on psychedelic stock news, The Fly looks back on...

25d ago

ATAI

CMND

Largest borrow rate increases among liquid names

Latest data shows the largest indicative borrow rate increases among liquid option names include: Twenty One Capital, Inc....

25d ago

MRK

NAK

Atai Beckley granted U.S. patent for EMP-01

Atai Beckley (ATAI) announced that the United States Patent and Trademark Office has granted a new patent covering...

25d ago

ATAI

Ametek, MindMed, Atai, Prime and KB Home Trending

Analysts are intrested in these 5 stocks: ( ($AME) ), ( ($MNMD) ), ( ($ATAI) ), ( ($PRME)...

9d ago

AME

KBH

ATAI Life Sciences Files Prospectus for Share Registration

ATAI Life Sciences ( ($ATAI) ) has provided an announcement. On December 5, 2025, Atai Beckley N.V. filed...

1M ago

ATAI

AtaiBeckley: Strong Buy Rating Backed by Promising Clinical Data and Robust Financial Position

Michael Okunewitch, an analyst from Maxim Group, maintained the Buy rating on ATAI Life Sciences. The associated price...

2M ago

ATAI

ATAI Life Sciences’ BPL-003 Gains Momentum with Breakthrough Therapy Designation and Strategic Merger, Reinforcing Buy Rating

H.C. Wainwright analyst Patrick Trucchio reiterated a Buy rating on ATAI Life Sciences today and set a price...

2M ago

ATAI

ATAI FAQ

What was ATAI Life Sciences’s price range in the past 12 months?

ATAI Life Sciences lowest stock price was $1.15 and its highest was $6.75 in the past 12 months.

What is ATAI Life Sciences’s market cap?

ATAI Life Sciences’s market cap is $1.41B.

When is ATAI Life Sciences’s upcoming earnings report date?

ATAI Life Sciences’s upcoming earnings report date is Mar 26, 2026 which is in 80 days.

How were ATAI Life Sciences’s earnings last quarter?

ATAI Life Sciences released its earnings results on Nov 12, 2025. The company reported -$0.28 earnings per share for the quarter, missing the consensus estimate of -$0.115 by -$0.165.

Is ATAI Life Sciences overvalued?

According to Wall Street analysts ATAI Life Sciences’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does ATAI Life Sciences pay dividends?

ATAI Life Sciences pays a Notavailable dividend of $6 which represents an annual dividend yield of N/A. See more information on ATAI Life Sciences dividends here

What is ATAI Life Sciences’s EPS estimate?

ATAI Life Sciences’s EPS estimate is -0.11.

How many shares outstanding does ATAI Life Sciences have?

ATAI Life Sciences has 363,214,600 shares outstanding.

What happened to ATAI Life Sciences’s price movement after its last earnings report?

ATAI Life Sciences reported an EPS of -$0.28 in its last earnings report, missing expectations of -$0.115. Following the earnings report the stock price went down -2.257%.

Which hedge fund is a major shareholder of ATAI Life Sciences?

Currently, no hedge funds are holding shares in ATAI

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

ATAI Life Sciences

Atai Beckley NV is a clinical-stage biopharmaceutical company. It engages in the treatment of mental health disorders. The company was founded by Christian Angermayer, Florian Brand, Srinivas Rao and Lars Christian Wilde in June 2018 and is headquartered in Amstelveen, Netherlands.

ATAI Life Sciences (ATAI) Earnings & Revenues

Historic Earnings Reports

ATAI Stock 12 Month Forecast

Average Price Target

$13.13

▲(239.28% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"0":"$0","17":"$17","4.25":"$4.25","8.5":"$8.5","12.75":"$12.75"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":16,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$16.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":13.13,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$13.13</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":10,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$10.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[0,4.25,8.5,12.75,17],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Mar<br/>2025","6":"Jun<br/>2025","9":"Sep<br/>2025","12":"Dec<br/>2025","25":"Dec<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3.84,4.775384615384615,5.71076923076923,6.646153846153846,7.581538461538461,8.516923076923078,9.452307692307691,10.387692307692308,11.323076923076922,12.258461538461539,13.193846153846154,14.12923076923077,15.064615384615385,{"y":16,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3.84,4.554615384615385,5.269230769230769,5.983846153846153,6.6984615384615385,7.413076923076924,8.127692307692307,8.842307692307692,9.556923076923077,10.271538461538462,10.986153846153847,11.70076923076923,12.415384615384616,{"y":13.13,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3.84,4.313846153846153,4.787692307692308,5.2615384615384615,5.735384615384615,6.2092307692307696,6.683076923076923,7.156923076923077,7.63076923076923,8.104615384615386,8.57846153846154,9.052307692307693,9.526153846153846,{"y":10,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":1.69,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.33,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.55,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.72,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.24,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.47,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.49,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.71,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.17,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.59,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.2,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.84,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.84,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >